Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 45.0134 | 27 |
GSM780708 | Untreated after 4 days (C2_1) | 50.2386 | 49 |
GSM780709 | Untreated after 4 days (C3_1) | 52.5463 | 55 |
GSM780719 | Untreated after 4 days (C1_2) | 49.0908 | 45 |
GSM780720 | Untreated after 4 days (C2_2) | 48.255 | 42 |
GSM780721 | Untreated after 4 days (C3_2) | 56.1313 | 61 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.5008 | 53 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 51.7245 | 53 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 54.0993 | 58 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 53.6928 | 57 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 53.7981 | 58 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 54.2953 | 58 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 54.5574 | 59 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 48.8637 | 45 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 48.5068 | 43 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 50.7164 | 51 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 52.9617 | 56 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 50.6148 | 50 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 54.1215 | 58 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 52.5384 | 55 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.5494 | 47 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.2933 | 49 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 52.8783 | 56 |